Literature DB >> 25966943

Protective role of Kv7 channels in oxygen and glucose deprivation-induced damage in rat caudate brain slices.

Vincenzo Barrese1,2, Maurizio Taglialatela2,3, Iain A Greenwood1, Colin Davidson1.   

Abstract

Ischemic stroke can cause striatal dopamine efflux that contributes to cell death. Since Kv7 potassium channels regulate dopamine release, we investigated the effects of their pharmacological modulation on dopamine efflux, measured by fast cyclic voltammetry (FCV), and neurotoxicity, in Wistar rat caudate brain slices undergoing oxygen and glucose deprivation (OGD). The Kv7 activators retigabine and ICA27243 delayed the onset, and decreased the peak level of dopamine efflux induced by OGD; and also decreased OGD-induced damage measured by 2,3,5-triphenyltetrazolium chloride (TTC) staining. Retigabine also reduced OGD-induced necrotic cell death evaluated by lactate dehydrogenase activity assay. The Kv7 blocker linopirdine increased OGD-evoked dopamine efflux and OGD-induced damage, and attenuated the effects of retigabine. Quantitative-PCR experiments showed that OGD caused an ~6-fold decrease in Kv7.2 transcript, while levels of mRNAs encoding for other Kv7 subunits were unaffected; western blot experiments showed a parallel reduction in Kv7.2 protein levels. Retigabine also decreased the peak level of dopamine efflux induced by L-glutamate, and attenuated the loss of TTC staining induced by the excitotoxin. These results suggest a role for Kv7.2 in modulating ischemia-evoked caudate damage.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25966943      PMCID: PMC4640310          DOI: 10.1038/jcbfm.2015.83

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  42 in total

1.  KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.

Authors:  Sarah Weckhuysen; Simone Mandelstam; Arvid Suls; Dominique Audenaert; Tine Deconinck; Lieve R F Claes; Liesbet Deprez; Katrien Smets; Dimitrina Hristova; Iglika Yordanova; Albena Jordanova; Berten Ceulemans; An Jansen; Danièle Hasaerts; Filip Roelens; Lieven Lagae; Simone Yendle; Thorsten Stanley; Sarah E Heron; John C Mulley; Samuel F Berkovic; Ingrid E Scheffer; Peter de Jonghe
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

2.  Novel role of KCNQ2/3 channels in regulating neuronal cell viability.

Authors:  X Zhou; J Wei; M Song; K Francis; S P Yu
Journal:  Cell Death Differ       Date:  2010-10-01       Impact factor: 15.828

3.  The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use.

Authors:  Charles H Large; David M Sokal; Astrid Nehlig; Martin J Gunthorpe; Raman Sankar; Christopher S Crean; Kevan E Vanlandingham; H Steve White
Journal:  Epilepsia       Date:  2012-01-05       Impact factor: 5.864

Review 4.  The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.

Authors:  Martin J Gunthorpe; Charles H Large; Raman Sankar
Journal:  Epilepsia       Date:  2012-01-05       Impact factor: 5.864

5.  The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.

Authors:  Majbrit M Jensen; Sofie C Lange; Morten S Thomsen; Henrik H Hansen; Jens D Mikkelsen
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-06-25       Impact factor: 4.080

6.  Apoptosis is not an invariable component of in vitro models of cortical cerebral ischaemia.

Authors:  Paul Alexander Jones; Gillian Ruth May; Joyee Ann McLuckie; Akinori Iwashita; John Sharkey
Journal:  Cell Res       Date:  2004-06       Impact factor: 25.617

7.  Characterization of a novel high-potency positive modulator of K(v)7 channels.

Authors:  William Dalby-Brown; Carsten Jessen; Charlotte Hougaard; Marianne L Jensen; Thomas A Jacobsen; Karin S Nielsen; Helle K Erichsen; Morten Grunnet; Philip K Ahring; Palle Christophersen; Dorte Strøbæk; Susanne Jørgensen
Journal:  Eur J Pharmacol       Date:  2013-04-03       Impact factor: 4.432

8.  Substantia nigra lesion protects against ischemic damage in the striatum.

Authors:  M Y Globus; M D Ginsberg; W D Dietrich; R Busto; P Scheinberg
Journal:  Neurosci Lett       Date:  1987-10-05       Impact factor: 3.046

Review 9.  Driving with no brakes: molecular pathophysiology of Kv7 potassium channels.

Authors:  Maria Virginia Soldovieri; Francesco Miceli; Maurizio Taglialatela
Journal:  Physiology (Bethesda)       Date:  2011-10

Review 10.  K(V)7 potassium channels: a new therapeutic target in smooth muscle disorders.

Authors:  Jennifer B Stott; Thomas A Jepps; Iain A Greenwood
Journal:  Drug Discov Today       Date:  2013-12-12       Impact factor: 7.851

View more
  5 in total

1.  Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, "M-type") K+ currents in neurons.

Authors:  Fabio A Vigil; Eda Bozdemir; Vladislav Bugay; Sang H Chun; MaryAnn Hobbs; Isamar Sanchez; Shayne D Hastings; Rafael J Veraza; Deborah M Holstein; Shane M Sprague; Chase M Carver; Jose E Cavazos; Robert Brenner; James D Lechleiter; Mark S Shapiro
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-04       Impact factor: 6.200

2.  The anticonvulsant retigabine suppresses neuronal KV2-mediated currents.

Authors:  Jeroen I Stas; Elke Bocksteins; Camilla S Jensen; Nicole Schmitt; Dirk J Snyders
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

Review 3.  Pharmacological Manipulation of K v 7 Channels as a New Therapeutic Tool for Multiple Brain Disorders.

Authors:  Fabio A Vigil; Chase M Carver; Mark S Shapiro
Journal:  Front Physiol       Date:  2020-06-19       Impact factor: 4.566

4.  Effect of Comprehensive Cerebral Protection Program on Cerebral Oxygen Metabolism and Vascular Endothelial Function in Elderly Patients with Acute Cerebral Infarction.

Authors:  Meihong Zhou; Zhaojun Huang
Journal:  Iran J Public Health       Date:  2019-02       Impact factor: 1.429

5.  Kcnq2/Kv7.2 controls the threshold and bi-hemispheric symmetry of cortical spreading depolarization.

Authors:  Isamu Aiba; Jeffrey L Noebels
Journal:  Brain       Date:  2021-10-22       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.